Concepedia

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, C Bouffioux, Louis Denis, Donald W. W. Newling, Karl‐Heinz Kurth

European Urology · 2006 · 3K citations · 38 references

DOI

Concepts

References

38

A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

Willem Oosterlinck, Karl H. Kurth, Fritz H. Schröder et al. · The Journal of Urology · 1993 · 367 citations

, , +12

PRIMARY SUPERFICIAL BLADDER CANCER RISK GROUPS ACCORDING TO PROGRESSION, MORTALITY AND RECURRENCE

F. Millán‐Rodríguez, G. Chéchile-Toniolo, J. SALVADOR-BAYARRI et al. · The Journal of Urology · 2000 · 345 citations

, , +12

Factors affecting recurrence and progression in superficial bladder tumours

K.H. Kurth, L. Denis, Ch. Bouffioux et al. · European Journal of Cancer · 1995 · 283 citations

, , +12

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy

Barthold Ph. Schrier, Maarten P. Hollander, Bas W.G. van Rhijn et al. · European Urology · 2003 · 270 citations

, , +10

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.

Adam Pawinski, Richard Sylvester, K. H. Kurth et al. · PubMed · 1996 · 264 citations

, , +15